GITNUXREPORT 2025

Biomedical Statistics

Biomedical research expenditures and innovation surged worldwide, boosting healthcare advancements significantly.

Jannik Lindner

Jannik Linder

Co-Founder of Gitnux, specialized in content and tech since 2016.

First published: April 29, 2025

Our Commitment to Accuracy

Rigorous fact-checking • Reputable sources • Regular updatesLearn more

Key Statistics

Statistic 1

68% of clinical trials worldwide are conducted with biomedical interventions

Statistic 2

The number of gene editing clinical trials is projected to double by 2025

Statistic 3

The average time from biomedical discovery to market approval is approximately 12 years

Statistic 4

The number of registered biomedical clinical trials worldwide surpassed 330,000 in 2022

Statistic 5

The percentage of pediatric biomedical clinical trials has increased by 15% over the last five years

Statistic 6

The number of biomedical patents filed globally increased by 12% from 2019 to 2021

Statistic 7

Approximately 70% of new drugs approved by the FDA between 2010 and 2020 were based on discoveries from biomedical research

Statistic 8

The number of biotech patents in China grew by over 22% from 2018 to 2022

Statistic 9

The average age of first-time biomedical patent filers is 45 years old

Statistic 10

The use of artificial intelligence in biomedical imaging diagnostics increased by 35% annually from 2018 to 2022

Statistic 11

The global biomedical market was valued at approximately $412 billion in 2022

Statistic 12

The global market for biotech and biomedical devices is projected to reach $612 billion by 2027

Statistic 13

The average cost to develop a new biomedical drug is estimated at $2.9 billion

Statistic 14

The number of biotech startups worldwide has grown by approximately 15% annually over the last five years

Statistic 15

The global CRISPR market size was valued at USD 0.6 billion in 2020 and is expected to grow at a CAGR of 19.8% from 2021 to 2028

Statistic 16

The global market for regenerative medicine is expected to reach $39 billion by 2025

Statistic 17

The global diagnostics market in biomedical testing is projected to reach $99 billion by 2025

Statistic 18

The annual growth rate of the biomedical devices sector has been around 4.5% over the past decade

Statistic 19

The global market for personalized medicine, a significant part of biomedical research, is projected to reach $149 billion by 2026

Statistic 20

The global market for antimicrobial resistance diagnostics is expected to reach $8 billion by 2027

Statistic 21

The use of telemedicine in biomedical care increased by over 50% during the COVID-19 pandemic

Statistic 22

The global market for biomedical sensors is projected to reach $12 billion by 2025

Statistic 23

Mobile health applications related to biomedical research saw a 70% increase in downloads globally during 2020-2022

Statistic 24

Worldwide spending on biomedical R&D is expected to reach nearly $300 billion annually by 2025

Statistic 25

Biomedical research funding in the United States exceeded $41 billion in 2021

Statistic 26

55% of biomedical research funding in Europe comes from public sources

Statistic 27

The top three areas of biomedical research funding are cancer, cardiovascular diseases, and neurosciences

Statistic 28

About 30% of biomedical research funding in the U.S. is allocated to cancer research alone

Statistic 29

Around 60% of biomedical research funding in Asia comes from government sources

Statistic 30

In 2022, the U.S. NIH allocated over $42 billion for biomedical research

Statistic 31

The use of biomedical nanotechnology has increased by over 18% annually since 2015

Statistic 32

Over 75% of biomedical research funding in Latin America is from local government sources

Statistic 33

The expenditure on biomedical research in Canada reached CAD 1.8 billion in 2020

Statistic 34

Over 80% of pharmaceutical companies invest in biomedical R&D to enhance drug discovery processes

Statistic 35

Over 1.5 million new biomedical research articles were published worldwide in 2021

Statistic 36

The number of biomedical PhD graduates in the U.S. increased by 4% annually from 2015 to 2020

Statistic 37

Biomedical journal publications increased by nearly 20% from 2018 to 2022

Statistic 38

The number of publications linking biomedical data and AI increased by over 25% annually from 2017 to 2021

Statistic 39

Approximately 40% of biomedical research articles are published open access

Statistic 40

The number of biomedical research institutions worldwide exceeds 22,000, with major growth in Asia and Europe

Statistic 41

Approximately 65% of biomedical research projects involve some form of computational modeling

Statistic 42

The use of 3D bioprinting in biomedical research increased by 30% from 2019 to 2022

Statistic 43

The number of biomedical research publications related to COVID-19 exceeded 200,000 by mid-2021

Statistic 44

The number of publications on biomedical machine learning increased by over 40% from 2019 to 2022

Statistic 45

The number of biomarkers identified in biomedical research has more than doubled over the last decade

Statistic 46

The proportion of biomedical research articles utilizing open-source data increased by 55% from 2016 to 2020

Statistic 47

Approximately 35% of biomedical research projects now incorporate patient-reported outcomes

Statistic 48

The adoption rate of multi-omics approaches in biomedical research increased by 20% annually from 2015 to 2020

Statistic 49

Biomedical research related to rare diseases represents about 10% of total biomedical publications

Slide 1 of 49
Share:FacebookLinkedIn
Sources

Our Reports have been cited by:

Trust Badges - Publications that have cited our reports

Key Highlights

  • The global biomedical market was valued at approximately $412 billion in 2022
  • Biomedical research funding in the United States exceeded $41 billion in 2021
  • Over 1.5 million new biomedical research articles were published worldwide in 2021
  • The number of biomedical patents filed globally increased by 12% from 2019 to 2021
  • Approximately 70% of new drugs approved by the FDA between 2010 and 2020 were based on discoveries from biomedical research
  • The global market for biotech and biomedical devices is projected to reach $612 billion by 2027
  • 55% of biomedical research funding in Europe comes from public sources
  • The number of biomedical PhD graduates in the U.S. increased by 4% annually from 2015 to 2020
  • The top three areas of biomedical research funding are cancer, cardiovascular diseases, and neurosciences
  • 68% of clinical trials worldwide are conducted with biomedical interventions
  • The average cost to develop a new biomedical drug is estimated at $2.9 billion
  • Biomedical journal publications increased by nearly 20% from 2018 to 2022
  • About 30% of biomedical research funding in the U.S. is allocated to cancer research alone

With the biomedical industry booming into a $412 billion global market and groundbreaking innovations like CRISPR and AI transforming healthcare, the future of medicine has never looked more promising — or more fast-paced.

Clinical Trials and Medical Development

  • 68% of clinical trials worldwide are conducted with biomedical interventions
  • The number of gene editing clinical trials is projected to double by 2025
  • The average time from biomedical discovery to market approval is approximately 12 years
  • The number of registered biomedical clinical trials worldwide surpassed 330,000 in 2022
  • The percentage of pediatric biomedical clinical trials has increased by 15% over the last five years

Clinical Trials and Medical Development Interpretation

With over 330,000 biomedical trials globally—doubling gene editing efforts and a burgeoning focus on pediatric research—it's clear that while we spend a dozen years from discovery to drug, the rapid pace of innovation signals a future where medicine may become as precise as it is swift.

Innovations, Technologies, and Patents

  • The number of biomedical patents filed globally increased by 12% from 2019 to 2021
  • Approximately 70% of new drugs approved by the FDA between 2010 and 2020 were based on discoveries from biomedical research
  • The number of biotech patents in China grew by over 22% from 2018 to 2022
  • The average age of first-time biomedical patent filers is 45 years old
  • The use of artificial intelligence in biomedical imaging diagnostics increased by 35% annually from 2018 to 2022

Innovations, Technologies, and Patents Interpretation

As biomedical innovation accelerates with a 12% global patent surge, China's biotech patent growth outpaces the age of first-time inventors at 45, while AI's diagnostic dominance climbs 35% annually—every statistic telling us that biotech's future isn't just promising, it's rapidly patenting its place in history.

Market Size and Economic Valuation

  • The global biomedical market was valued at approximately $412 billion in 2022
  • The global market for biotech and biomedical devices is projected to reach $612 billion by 2027
  • The average cost to develop a new biomedical drug is estimated at $2.9 billion
  • The number of biotech startups worldwide has grown by approximately 15% annually over the last five years
  • The global CRISPR market size was valued at USD 0.6 billion in 2020 and is expected to grow at a CAGR of 19.8% from 2021 to 2028
  • The global market for regenerative medicine is expected to reach $39 billion by 2025
  • The global diagnostics market in biomedical testing is projected to reach $99 billion by 2025
  • The annual growth rate of the biomedical devices sector has been around 4.5% over the past decade
  • The global market for personalized medicine, a significant part of biomedical research, is projected to reach $149 billion by 2026
  • The global market for antimicrobial resistance diagnostics is expected to reach $8 billion by 2027
  • The use of telemedicine in biomedical care increased by over 50% during the COVID-19 pandemic
  • The global market for biomedical sensors is projected to reach $12 billion by 2025
  • Mobile health applications related to biomedical research saw a 70% increase in downloads globally during 2020-2022
  • Worldwide spending on biomedical R&D is expected to reach nearly $300 billion annually by 2025

Market Size and Economic Valuation Interpretation

With a nearly $300 billion annual investment fueling a projected $612 billion biotech market by 2027, a 15% yearly surge in startups, and breakthroughs like CRISPR and telemedicine transforming global healthcare, the biomedical landscape is not just booming—it's racing toward a future where personalized, regenerative, and digital medicine become the new standard, albeit at a hefty price tag and with challenges as vast as its promise.

Research Funding and Investments

  • Biomedical research funding in the United States exceeded $41 billion in 2021
  • 55% of biomedical research funding in Europe comes from public sources
  • The top three areas of biomedical research funding are cancer, cardiovascular diseases, and neurosciences
  • About 30% of biomedical research funding in the U.S. is allocated to cancer research alone
  • Around 60% of biomedical research funding in Asia comes from government sources
  • In 2022, the U.S. NIH allocated over $42 billion for biomedical research
  • The use of biomedical nanotechnology has increased by over 18% annually since 2015
  • Over 75% of biomedical research funding in Latin America is from local government sources
  • The expenditure on biomedical research in Canada reached CAD 1.8 billion in 2020
  • Over 80% of pharmaceutical companies invest in biomedical R&D to enhance drug discovery processes

Research Funding and Investments Interpretation

With over $42 billion funneled into biomedical research in the U.S. alone, and a global mosaic where public funds largely fuel the quest against cancer, cardiovascular diseases, and neurosciences, it's clear that governments and industry alike are rapidly investing in the microscopic frontier—like nanotechnology growing over 18% annually—to turn scientific curiosity into life-saving innovation.

Research Output, Publications, and Academic Trends

  • Over 1.5 million new biomedical research articles were published worldwide in 2021
  • The number of biomedical PhD graduates in the U.S. increased by 4% annually from 2015 to 2020
  • Biomedical journal publications increased by nearly 20% from 2018 to 2022
  • The number of publications linking biomedical data and AI increased by over 25% annually from 2017 to 2021
  • Approximately 40% of biomedical research articles are published open access
  • The number of biomedical research institutions worldwide exceeds 22,000, with major growth in Asia and Europe
  • Approximately 65% of biomedical research projects involve some form of computational modeling
  • The use of 3D bioprinting in biomedical research increased by 30% from 2019 to 2022
  • The number of biomedical research publications related to COVID-19 exceeded 200,000 by mid-2021
  • The number of publications on biomedical machine learning increased by over 40% from 2019 to 2022
  • The number of biomarkers identified in biomedical research has more than doubled over the last decade
  • The proportion of biomedical research articles utilizing open-source data increased by 55% from 2016 to 2020
  • Approximately 35% of biomedical research projects now incorporate patient-reported outcomes
  • The adoption rate of multi-omics approaches in biomedical research increased by 20% annually from 2015 to 2020
  • Biomedical research related to rare diseases represents about 10% of total biomedical publications

Research Output, Publications, and Academic Trends Interpretation

The biomedical research landscape is exploding in volume and complexity—from over 1.5 million articles published globally in 2021 to a staggering 40% open access, and with AI and multi-omics fueling a data-driven revolution, it's clear that while the pace of discovery accelerates, the challenge now lies in navigating this vast seas of knowledge to turn data into meaningful cures.

Sources & References